MRNA | Moderna Prepares to Launch COVID-19 Vaccine Candidate

Moderna (NASDAQ: MRNA) is getting ready to publicly introduce its trial coronavirus vaccine.According to the firm, it has already accepted USD1.1 Billion in deposits from governments waiting to use the drug.Shares rose over 3% during midmorning trading.Similar to various other drugmakers, Moderna is in a race to develop a vaccine for the…Financial Buzz